Ocular Therapeutix

BEDFORD, Mass. — September 15, 2026 Ocular Therapeutix, Inc. announced the successful completion of its Pre-New Drug Application (Pre-NDA)...

BEDFORD, Mass., April 13, 2026 Ocular Therapeutix, Inc. has reported positive Week 52 data from its Phase 3 SOL-1...